BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 3, 2008
View Archived Issues
Medarex Shares Take Hit Amid Pfizer's Halted Melanoma Trial
Medarex shares plummeted Wednesday as partner Pfizer Inc. unexpectedly halted a Phase III trial of potential melanoma treatment tremelimumab. (BioWorld Today)
Read More
Trial Data Could Prompt ISTA to Tweak Xibrom Formulations
Read More
Papers Agree on Lung Cancer Risk Genes, Disagree on Why
Read More
FDA Panel Supports Use of Noninferiority Studies for CAP
Read More
Genta Cutting Staff, Selling Ganite in Wake of Rejection
Read More
Generex Raising $20.7M Privately For Oral-lyn Insulin Spray Trials
Read More
Other News To Note
Read More
Clinic Roundup
Read More